Summary
PHARMATEL is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.1m and a net result of €429,692. Equity is shrinking by about 4.1% per year across the filed financial years. Its solvency ranks better than 62% of 9,643 sector peers (NACE 64, financial year 2025). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Financial yearThe twelve-month period the company draws up its annual accounts for.
- From 1 July to 30 June
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- 15 December at 15:00
Read from the deeds: 2 provisions, deed of 11-05-2026